Please use the links at the top of the page to navigate through our site.

2022 Update
Association of Police Controlled Drug Liaison Officers

We have received a number of enquiries from companies / applicants who intend to apply to the Home Office for a licence in respect of the below Governments Response to the report by the Advisory Council on the Misuse of Drugs (ACMD) legislation which came into effect on 15.6.22.

​

Government’s response  

The ACMD’s report “An assessment of the harms of gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and closely related compounds”.

I am mindful of the ACMD’s advice that the recommendations be considered as a single package, and of the Council’s concern to avoid unintended consequences. However, I also agree that action is needed to implement the legislative recommendations that will tighten the law on these substances, and I therefore agree to Recommendation 3 (that GHB, GBL and 1,4-butanediol (1,4-BD) be moved from Class C to Class B of the Misuse of Drugs Act 1971) and Recommendation 4 (that GBL and 1,4-BD are placed under Schedule 1 of the Misuse of Drugs Regulations 2001, so that industrial users will require a controlled drug licence). It is my view that we should begin the process of amending the legislation to implement Recommendations 3 and 4, subject to Parliamentary approval, as soon as possible.

​

If you are a business seeking a controlled drug licence, it may help ypur application to visit the below which should answer most of the questions you may have.

https://www.gov.uk/government/publications/general-security-guidance-for-controlled-drug-suppliers

 

https://www.gov.uk/government/publications/transporting-controlled-drugs-guidance-on-security-measures

 

If further advice is required, our association suggests you contact DFLU.dom@homeoffice.gov.uk

rather than the APCDLO.